Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease

Medicine (United States)

Volumn 94, Issue 45, 2015, Pages e1773-

  Yu, Qiao ^a   Zhang, Shenghong ^a   Li, Li ^a   Xiong, Lishou ^a   Chao, Kang ^a   Zhong, Bihui ^a   Li, Yuwen ^a   Wang, Huiling ^a   Chen, Minhu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CROHN DISEASE; HELICOBACTER PYLORI; HUMAN; INTESTINE MUCOSA; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; HELICOBACTER; INFLAMMATORY BOWEL DISEASE; ISOLATION AND PURIFICATION; MICROBIOLOGY;

HELICOBACTER; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84958183025     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001773     Document Type: Review

References (47)

1. M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;14:33-47.
2. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-519.
3. Mateos-Munoz B, Perez-de-la-Serna J, Ruiz-de-Leon A, et al. Enterohepatic Helicobacter other than Helicobacter pylori. Rev Esp Enferm Dig. 2013;105:477-485.
4. Frank DN, St AA, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-13785.
5. Nagalingam NA, Robinson CJ, Bergin IL, et al. The effects of intestinal microbial community structure on disease manifestation in IL-10-/-mice infected with Helicobacter hepaticus. Microbiome. 2013;1:15.
6. Yang I, Eibach D, Kops F, et al. Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS ONE. 2013;8: e70783.
7. Muthupalani S, Ge Z, Feng Y, et al. Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokinemediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/-mouse model of inflammatory bowel disease. Infect Immun. 2012;80:4388-4397.
8. Manichanh C, Borruel N, Casellas F, et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599-608.
9. Megraud F. A humble bacterium sweeps this year's Nobel Prize. Cell. 2005;123:975-976.
10. Luther J, Owyang SY, Takeuchi T, et al. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut. 2011;60:1479-1486.
11. Luther J, Dave M, Higgins PD, et al. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16:1077-1084.
12. Rokkas T, Gisbert JP, Niv Y, et al. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. UEG J. 2015doi: 10.1177/2050640615580889.
13. Wu XW, Ji HZ, Yang MF, et al. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol. 2015;21:4750-4756.
14. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
15. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
16. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-605.
17. Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:1-173.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
20. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
22. DerSimonian R, Kacker R. Random-effects model for metaanalysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105-114.
23. Tomoda A, Miyazawa K, Tabuchi T. Prevention of carcinogenesis and development of gastric and colon cancers by 2-aminophenoxazine-3-one (Phx-3): direct and indirect anti-cancer activity of Phx-3. Int J Mol Sci. 2013;14:17573-17583.
24. Xiang Z, Chen YP, Ye YF, et al. Helicobacter pylori and Crohn's disease: a retrospective single-center study from China. World J Gastroenterol. 2013;19:4576-4581.
25. Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469-476.
26. Basset C, Holton J, Bazeos A, et al. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci. 2004;49:1425-1432.
27. Bohr UR, Primus A, Zagoura A, et al. A group-specific PCR assay for the detection of Helicobacteraceae in human gut. Helicobacter. 2002;7:378-383.
28. Duchmann R, Marker-Hermann E, Meyer ZBK. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol. 1996;44:71-79.
29. Bell SJ, Chisholm SA, Owen RJ, et al. Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18:481-486.
30. Huijsdens XW, Linskens RK, Koppes J, et al. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunol Med Microbiol. 2004;41:79-84.
31. Tiveljung A, Soderholm JD, Olaison G, et al. Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J Med Microbiol. 1999;48:263-268.
32. Bohr UR, Glasbrenner B, Primus A, et al. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol. 2004;42:2766-2768.
33. Grehan M, Danon S, Lee A, et al. Absence of mucosa-associated colonic Helicobacters in an Australian urban population. J Clin Microbiol. 2004;42:874-876.
34. Streutker CJ, Bernstein CN, Chan VL, et al. Detection of speciesspecific helicobacter ribosomal DNA in intestinal biopsy samples from a population-based cohort of patients with ulcerative colitis. J Clin Microbiol. 2004;42:660-664.
35. Zhang L, Day A, McKenzie G, et al. Nongastric Helicobacter species detected in the intestinal tract of children. J Clin Microbiol. 2006;44:2276-2279.
36. Oliveira AG, Rocha GA, Rocha AM, et al. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter. 2006;11:2-9.
37. Laharie D, Asencio C, Asselineau J, et al. Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther. 2009;30: 283-293.
38. Kaakoush NO, Holmes J, Octavia S, et al. Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter. 2010;15:549-557.
39. Thomson JM, Hansen R, Berry SH, et al. Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS ONE. 2011;6:e17184.
40. Zhang S, Zhong B, Chao K, et al. Role of Helicobacter species in Chinese patients with inflammatory bowel disease. J Clin Microbiol. 2011;49:1987-1989.
41. Hansen R, Berry SH, Mukhopadhya I, et al. The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS ONE. 2013;8:e58825.
42. Oliveira AG, Das GPSM, Rocha GA, et al. Helicobacter species in the intestinal mucosa of patients with ulcerative colitis. J Clin Microbiol. 2004;42:384-386.
43. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607.
44. Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630-649.
45. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449-490.
46. Cellini L, Marzio L, Ferrero G, et al. Transmission of Helicobacter pylori in an animal model. Dig Dis Sci. 2001;46:62-68.
47. Fox JG. The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut. 2002;50:273-283.